These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29575236)

  • 21. Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling.
    Shi L; Sun G; Zhu H
    Aging (Albany NY); 2020 Jul; 12(14):14718-14735. PubMed ID: 32710727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.
    Toren A; Pismenyuk T; Yalon M; Freedman S; Simon AJ; Fisher T; Moshe I; Reichardt JK; Constantini S; Mardor Y; Last D; Guez D; Daniels D; Assoulin M; Mehrian-Shai R
    Oncotarget; 2016 Nov; 7(46):74860-74871. PubMed ID: 27556862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy.
    Dinca EB; Sarkaria JN; Schroeder MA; Carlson BL; Voicu R; Gupta N; Berger MS; James CD
    J Neurosurg; 2007 Sep; 107(3):610-6. PubMed ID: 17886562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoamine oxidase A (MAO A) inhibitors decrease glioma progression.
    Kushal S; Wang W; Vaikari VP; Kota R; Chen K; Yeh TS; Jhaveri N; Groshen SL; Olenyuk BZ; Chen TC; Hofman FM; Shih JC
    Oncotarget; 2016 Mar; 7(12):13842-53. PubMed ID: 26871599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
    Anai S; Hide T; Takezaki T; Kuroda J; Shinojima N; Makino K; Nakamura H; Yano S; Kuratsu J
    Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma.
    Si J; Li W; Li X; Cao L; Chen Z; Jiang Z
    Cancer Sci; 2021 Sep; 112(9):3491-3506. PubMed ID: 34036683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sitagliptin inhibits the survival, stemness and autophagy of glioma cells, and enhances temozolomide cytotoxicity.
    You F; Li C; Zhang S; Zhang Q; Hu Z; Wang Y; Zhang T; Meng Q; Yu R; Gao S
    Biomed Pharmacother; 2023 Jun; 162():114555. PubMed ID: 36966667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging temozolomide-induced changes in the myeloid glioma microenvironment.
    Foray C; Valtorta S; Barca C; Winkeler A; Roll W; Müther M; Wagner S; Gardner ML; Hermann S; Schäfers M; Grauer OM; Moresco RM; Zinnhardt B; Jacobs AH
    Theranostics; 2021; 11(5):2020-2033. PubMed ID: 33500706
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells.
    Shi L; Gao LL; Cai SZ; Xiong QW; Ma ZR
    Eur J Med Chem; 2021 Oct; 221():113528. PubMed ID: 34020339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
    Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
    Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
    Kim JS; Shin DH; Kim JS
    J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
    Zhang X; Ni Q; Wang Y; Fan H; Li Y
    Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model.
    Fujihara T; Mizobuchi Y; Nakajima K; Kageji T; Matsuzaki K; Kitazato KT; Otsuka R; Hara K; Mure H; Okazaki T; Kuwayama K; Nagahiro S; Takagi Y
    J Neurooncol; 2018 Sep; 139(2):323-332. PubMed ID: 29779087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
    Son MJ; Kim JS; Kim MH; Song HS; Kim JT; Kim H; Shin T; Jeon HJ; Lee DS; Park SY; Kim YJ; Kim JH; Nam DH
    Int J Oncol; 2006 Jan; 28(1):53-9. PubMed ID: 16327979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model.
    Azambuja JH; Schuh RS; Michels LR; Gelsleichter NE; Beckenkamp LR; Lenz GS; de Oliveira FH; Wink MR; Stefani MA; Battastini AMO; Teixeira HF; Braganhol E
    Cancer Chemother Pharmacol; 2020 Jun; 85(6):1177-1182. PubMed ID: 32417936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study.
    Yu Y; Wang L; Han J; Wang A; Chu L; Xi X; Kan R; Sha C; Sun K
    J Pharm Sci; 2021 Oct; 110(10):3431-3438. PubMed ID: 34147518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.
    Kim JT; Kim JS; Ko KW; Kong DS; Kang CM; Kim MH; Son MJ; Song HS; Shin HJ; Lee DS; Eoh W; Nam DH
    Oncol Rep; 2006 Jul; 16(1):33-9. PubMed ID: 16786120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation.
    Yu G; Wu F; Wang E
    Cell Physiol Biochem; 2016; 38(4):1596-604. PubMed ID: 27081861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma.
    Zeng X; Wang Q; Tan X; Jia L; Li Y; Hu M; Zhang Z; Bai X; Zhu Y; Yang X
    J Nanobiotechnology; 2019 Apr; 17(1):47. PubMed ID: 30935403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.